Study identifies five kinds of diabetes, potentially changing treatment
March 2, 2018Medical Communications, Research and Development biotech, diabetes, drugs, pharma, pharmaceutical
A decade-long study has unearthed findings that could entirely change how people living with diabetes are treated, after the classic …
Artificial Cell Technologies CFO accused of stealing nearly $1m in company funds
March 2, 2018Medical Communications, Sales and Marketing Artificial Cell Technologies, cfo, pharma
A high-ranking C-level executive of a US biotech start-up has been charged with embezzling almost $1 million from the company …
Novartis forms a Pear to develop mobile therapies
March 2, 2018Medical Communications, Research and Development Novartis, Pear Therapeutics, biotech, drugs, pharma, pharmaceutical
Novartis has announced an agreement between Pear Therapeutics and itself to develop two digital therapeutics, one in schizophrenia and one …
Ipsen: Becoming a “development powerhouse”
March 1, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing David Meek, Insider Interview, ipsen, pharma
Immediately following the release of impressive full year financials, Ipsen CEO David Meek speaks on how the company is hitting …
Takeda to create 70 jobs with €25m Dublin investment
March 1, 2018Manufacturing and Production Dublin, Takeda, pharma
Takeda has announced its investment of €25 million to construct a new “modular cell therapy facility dedicated to manufacturing a …
Merck/Pfizer’s Bavencio wins slight reprieve after NICE nod
March 1, 2018Medical Communications, Sales and Marketing Bavencio, Merck, Pfizer, biotech, drugs, pharma, pharmaceutical
Just two weeks ago, Merck KGaA and Pfizer were hit with a major setback for their PD-L1 immunotherapy, Bavencio, after …
Europe approves first therapy for haemophilia A with inhibitors in over 20 years
March 1, 2018Research and Development Europe, European Commission, Hemlibra, Roche, haemophilia, pharma
Roche has revealed that its bispecific factor IXa- and factor X-directed antibody Hemlibra (emicizumab) has been approved by the European …
Mylan looks to muscle in on Allergan’s Botox territory
March 1, 2018Sales and Marketing Botox, Mylan, Revance Therapeutics, biotech, drugs, epipen, pharma, pharmaceutical
Mylan announced, alongside its financials, that it had signed a global collaboration and licensing agreement with Revance Therapeutics to partner …
EMA set to also revise guidelines of Alzheimer’s trials
February 28, 2018Medical Communications Alzheimer's, EMA, FDA, biotech, drugs, pharma, pharmaceutical
The EMA, following on from the FDA’s lead earlier this month, has announced that it will revise its guidelines on …
Stem cell therapy offers hope for spinal cord injuries
February 28, 2018Research and Development biotech, drugs, pharma, pharmaceutical, stem cell, stem cell treatment
Scientists have brought the prospect of spinal cord injuries being able to be treated with stem cells one step closer, …
FDA refuses to review Celgene’s ozanimod in multiple sclerosis
February 28, 2018Research and Development, Sales and Marketing Celgene, FDA, multiple sclerosis, ozanimod, pharma
Celgene has been dealt a heavy blow, revealing that the FDA has rejected its New Drug Application for its sphingosine …
AstraZeneca creates biotech spin-off, $250m in bank
February 28, 2018Research and Development, Sales and Marketing AstraZeneca, Viela, biotech, drugs, pharma, pharmaceutical
Biotechs created from big pharma companies tend to have an easier start to life than most, and this is definitely …
Pharmafocus March 2018 is available to read online now!
February 28, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pharmafocus, brexit, drug safety, pharma, real world data
Though never truly out of vogue, the drug pricing debate has flared up again with the White House’s release of …
Generation Bio backed with $100m financing round
February 28, 2018Research and Development, Sales and Marketing Generation Bio, biotech, drugs, pharma, pharmaceutical
At the start of year, Generation Bio was revealed to the public, announcing that it had been developing gene therapies …
UK Government announces prescription price hike to record level
February 27, 2018Manufacturing and Production, Medical Communications, Sales and Marketing NHS, pharma, prescription, price
The UK Government has announced plans to increase prescription charges by 20p, or 2.3%, to a record £8.80, effective 1 …
Allergan’s patent gamble fails
February 27, 2018Manufacturing and Production, Medical Communications Allergan, Mylan, biotech, drugs, patent, pharma, pharmaceutical
Allergan’s patent deal with the Saint Regis Mohawk Tribe, in an attempt to protect itself from an inter partes review …
FDA to fight opioid crisis with wider access to medication-assisted treatment
February 27, 2018Manufacturing and Production, Medical Communications, Research and Development Alex Azar, FDA, medication-assisted treatment, opioid crisis, opioids, pharma
The FDA is set to refocus its efforts in combating the United States’ opioid crisis. Speaking at a meeting of …
UK govt report looks to reduce vaccination spending
February 27, 2018Manufacturing and Production, Medical Communications Vaccine, biotech, drugs, meningitis, pharma, pharmaceutical
One of the largest petitions ever to have gone before UK parliament, after it attracted 823,349 signatures, brought about the …
FDA expands indication of Lilly’s Verzenio in advanced breast cancer
February 27, 2018Manufacturing and Production, Sales and Marketing Cancer, Eli Lilly, FDA, Verzenio, breast cancer, pharma
Eli Lilly is celebrating the news that its cyclin-dependent kinase (CDK) 4 & 6 inhibitor Verzenio (ademaciclib) has received approval …
UK to crack down on 237m annual medication errors
February 23, 2018Medical Communications Jeremy Hunt, NHS, biotech, drugs, pharma, pharmaceutical
A new study commissioned by the Department of Health and Social Care has revealed that 237 million medication errors are …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
